Cargando…
Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins
Since the beginning of the COVID-19 pandemic, considerable efforts have been made to develop protective vaccines against SARS-CoV-2 infection. However, immunity tends to decline within a few months, and new virus variants are emerging with increased transmissibility and capacity to evade natural or...
Autores principales: | Polo-Megías, Daniel, Cano-Muñoz, Mario, Berruezo, Alberto G., Laumond, Géraldine, Moog, Christiane, Conejero-Lara, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778920/ https://www.ncbi.nlm.nih.gov/pubmed/36555153 http://dx.doi.org/10.3390/ijms232415511 |
Ejemplares similares
-
Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity
por: Cano-Muñoz, Mario, et al.
Publicado: (2022) -
Conformational Stabilization of Gp41-Mimetic Miniproteins Opens Up New Ways of Inhibiting HIV-1 Fusion
por: Cano-Muñoz, Mario, et al.
Publicado: (2022) -
Extremely Thermostabilizing Core Mutations in Coiled-Coil Mimetic Proteins of HIV-1 gp41 Produce Diverse Effects on Target Binding but Do Not Affect Their Inhibitory Activity
por: Cano-Muñoz, Mario, et al.
Publicado: (2021) -
Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
por: Mayr, Luzia M., et al.
Publicado: (2017) -
Neutralizing Antibodies Inhibit HIV-1 Infection of Plasmacytoid Dendritic Cells by an FcγRIIa Independent Mechanism and Do Not Diminish Cytokines Production
por: Lederle, Alexandre, et al.
Publicado: (2014)